Sido Muncul Bundle
Who Really Owns Sido Muncul?
Understanding the Sido Muncul SWOT Analysis is crucial, but have you ever wondered about the individuals and entities steering this Indonesian giant? The story of PT Industri Jamu dan Farmasi Sido Muncul Tbk, or Sido Muncul, is a fascinating journey from a family business to a publicly traded company. Unraveling the Sido Muncul ownership structure reveals key players and strategic shifts that have shaped its success.
From its humble beginnings in 1940, Sido Muncul's evolution is a testament to its resilience and strategic adaptation. The company's IPO in 2013 marked a significant turning point, introducing new stakeholders and dynamics to the already successful business. Exploring the Sido Muncul owner and ownership structure is key to understanding its future trajectory and its place in the Indonesian market.
Who Founded Sido Muncul?
The story of the company begins in 1940, marking its start as a home-based business in Surakarta. The founder, Mrs. Rakhmat Sulistio, initially created a herbal medicine recipe for colds, which later became the well-known 'Tolak Angin'. Understanding the Sido Muncul owner and Sido Muncul ownership is key to understanding its journey from a small family business to a significant player in the Indonesian pharmaceutical industry.
In 1951, the company officially adopted the name 'Sido Muncul' and established its production. The company's evolution reflects a blend of traditional practices and modern business strategies. Understanding the early ownership structure provides insight into the values and vision that shaped the company.
The company's transformation from a home business to a formal entity highlights its growth. The evolution of Sido Muncul ownership structure reflects the company's adaptation to the changing business environment.
Founding and Early Days
Mrs. Rakhmat Sulistio, also known as Go Djing Nio, founded the company in 1940. She started by creating a herbal medicine recipe for colds, which later became 'Tolak Angin'.
Relocation and Formalization
Due to the Indonesian National Revolution, the company moved to Semarang in 1949. In 1951, the production was established, and the name 'Sido Muncul' was adopted.
Early Ownership Structure
In 1953, Mrs. Rakhmat Sulistio's daughter, Desy Sulistio, and her husband, Jahja Hidajat, joined the company, acquiring a 50% stake. This marked a significant shift in the company's ownership.
Transition and Management
Desy Sulistio and Jahja Hidajat took over management when Mrs. Rakhmat Sulistio retired in 1970. Jahja Hidajat passed away in 1994.
Legal Structure
The company was registered as a CV (Commanditaire Vennootschap) in 1970. Later, it transformed into a Limited Liability Company (PT Industri Jamu dan Farmasi Sido Muncul) in 1975.
Legacy of Founders
The founding family's focus on natural ingredients and traditional recipes has been a cornerstone of the company's success. The continued popularity of 'Tolak Angin' is a testament to this legacy.
Key Takeaways
The early history of the company reveals a journey from a home-based herbal medicine business to a structured, legally registered entity. The founders' vision and the evolution of ownership played a crucial role in shaping the company's identity and success. For more detailed information, you can explore the Competitors Landscape of Sido Muncul.
- Mrs. Rakhmat Sulistio's initial formulation of 'Tolak Angin' in 1940 marked the beginning.
- The involvement of Desy Sulistio and Jahja Hidajat in 1953 brought in new management and ownership.
- The transition to a CV in 1970 and a PT in 1975 formalized the business structure.
- The legacy of the founders continues to influence the company's product development and values.
Sido Muncul SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Sido Muncul’s Ownership Changed Over Time?
The journey of the Sido Muncul owner has been marked by key events, especially the shift to public status. PT Industri Jamu dan Farmasi Sido Muncul Tbk (IDX: SIDO) entered the public market on December 18, 2013. Initially, the founding family retained a significant hold, controlling around 81% of the shares, even six months post-IPO. This move signaled a strategic step in the company's evolution while maintaining the family's influence.
A significant change occurred in April 2024. Affinity Equity Partners, who had invested approximately USD 180 million for a 21.1% stake in late 2017, divested its remaining 17.1% ownership back to the controlling shareholder, the Hidayat family. This transaction, valued at USD 233 million (IDR 3.69 trillion), saw the family repurchase shares at IDR 719 per share, a 105% premium over Affinity's initial investment. This action highlights the family's dedication to maintaining control and recognizing the company's value.
| Event | Date | Details |
|---|---|---|
| Initial Public Offering (IPO) | December 18, 2013 | The company went public, with the founding family retaining a majority stake. |
| Affinity Equity Partners Investment | Late 2017 | Affinity Equity Partners invested approximately USD 180 million for a 21.1% stake. |
| Affinity Equity Partners Divestment | April 2024 | Affinity Equity Partners sold its remaining 17.1% stake back to the Hidayat family for USD 233 million. |
As of February 2025, the Hidayat family, through Hotel Candi Baru, remains the primary Sido Muncul owner, holding a 77.6% stake. The remaining 22.4% is held by the public. Key individuals from the Hidayat family, including Irwan Hidayat and David Hidayat, are actively involved in the company's management. David Hidayat currently serves as the President Director. The five Hidayat siblings collectively own the majority stake, ensuring their strategic vision continues to guide the company, as explored in detail in Growth Strategy of Sido Muncul.
Key Ownership Facts
The Hidayat family, through Hotel Candi Baru, holds a 77.6% stake as of February 2025, making them the majority owner.
- The IPO occurred on December 18, 2013.
- Affinity Equity Partners fully divested in April 2024.
- David Hidayat is the current President Director.
- The family's control ensures continuity in strategic direction.
Sido Muncul PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Sido Muncul’s Board?
The governance of PT Industri Jamu dan Farmasi Sido Muncul Tbk, often referred to as the Sido Muncul company, is significantly shaped by its Board of Directors. As of the latest available information from 2024 and 2025, the board includes key figures from the founding family, ensuring continuity and strategic direction. This structure is crucial in understanding the Sido Muncul ownership and how decisions are made within the company.
The current Board of Directors includes David Hidayat as President Director, along with Irwan Hidayat, Darmadji Sidik, Budiyanto, and Maria Reviani as Directors. The Board of Commissioners is led by Jonatha Sofjan Hidajat as President Commissioner, supported by Johan Hidayat, Sigit Hartojo Hadi Santoso, Lindawati Gani, Dokter Mohammad Adib Khumaidi, and Venancia Sri Indrijati Wijono as Commissioners. Lindawati Gani and Dokter Mohammad Adib Khumaidi are noted as independent commissioners, bringing diverse perspectives to the company's oversight.
| Position | Name | Role |
|---|---|---|
| President Director | David Hidayat | Oversees daily operations |
| Director | Irwan Hidayat | Contributes to strategic planning |
| President Commissioner | Jonatha Sofjan Hidajat | Leads the Board of Commissioners |
The Hidayat family's substantial ownership, primarily through Hotel Candi Baru, which held 77.6% of the company's shares as of February 2025, grants them considerable voting power. This significant stake directly influences the company's strategic direction and major decisions. For more insights into the company's origins, you can explore the Brief History of Sido Muncul. The company's investor relations reports, including monthly updates on shareholder registers and the outcomes of annual general meetings, provide ongoing transparency regarding ownership and governance, offering valuable information for anyone interested in who owns Sido Muncul.
Ownership and Control
The Hidayat family's majority ownership gives them significant control over the company.
- The family's stake is held primarily through Hotel Candi Baru.
- The ownership structure grants substantial voting power.
- Investor relations reports provide transparency.
- This structure is key to understanding Sido Muncul's strategic direction.
Sido Muncul Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Sido Muncul’s Ownership Landscape?
Over the past few years, the ownership of PT Industri Jamu dan Farmasi Sido Muncul Tbk, commonly known as Sido Muncul, has seen significant developments. A major change occurred in April 2024, when the Hidayat family repurchased the entire 17.1% stake previously held by Affinity Equity Partners. This transaction, valued at approximately USD 233 million (IDR 3.69 trillion), increased the Hidayat family's controlling stake to 77.6%. This move highlights the family's commitment to maintaining control and their confidence in the company's future. The buyback, done at a premium, shows a strategic effort to consolidate ownership.
Further solidifying the ownership structure, board members have recently increased their holdings. In February 2025, David Hidayat, the President Director, purchased additional shares worth IDR 5.2 billion. This increased his ownership by 0.031%. This insider buying sends a positive signal to the market, reflecting strong confidence from the company's leadership. These actions provide insights into the dynamics of Sido Muncul ownership and its impact on the company's trajectory.
Industry trends in Indonesia's herbal medicine and pharmaceutical sectors indicate a mix of family control and institutional investment for publicly listed companies. Sido Muncul's strong financial performance in 2024, with a net profit of IDR 1.17 trillion and sales of IDR 3.92 trillion, aligns well with these trends. The company projects a 10% sales growth and up to 10% net profit growth for 2025, driven by product sales volume and selective price increases. This outlook supports a stable view of its ownership structure. Moreover, the announcement of a proposed share buyback in March 2025 suggests active management of its capital structure. To learn more about the company's marketing strategies, you can read this article: Marketing Strategy of Sido Muncul.
Key Development
The Hidayat family increased their stake to 77.6% by repurchasing shares from Affinity Equity Partners in April 2024.
Insider Buying
President Director David Hidayat purchased shares in February 2025, showing leadership confidence.
Financial Performance
Sido Muncul reported a net profit of IDR 1.17 trillion and sales of IDR 3.92 trillion in 2024.
Future Outlook
The company projects 10% sales and up to 10% net profit growth for 2025, along with a share buyback.
Sido Muncul Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Sido Muncul Company?
- What is Competitive Landscape of Sido Muncul Company?
- What is Growth Strategy and Future Prospects of Sido Muncul Company?
- How Does Sido Muncul Company Work?
- What is Sales and Marketing Strategy of Sido Muncul Company?
- What is Brief History of Sido Muncul Company?
- What is Customer Demographics and Target Market of Sido Muncul Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.